XML 77 R65.htm IDEA: XBRL DOCUMENT v3.22.2
Collaboration and License Agreements - Performance Obligations (Details) - Collaborative Arrangement
6 Months Ended
Jun. 30, 2022
component
item
Zai Lab (Shanghai) Co., Ltd.  
Performance Obligations  
Collaborative arrangement, material promises, number 3
Collaborative arrangement, material promises, combined into distinct performance obligation, number 2
Collaborative arrangement, material components, number | component 2
Roche, Collaboration (Pralsetnib) Agreement  
Performance Obligations  
Collaborative arrangement, material promises, number 1
Collaborative arrangement, material promises, manufacturing activities, term 24 months
Collaborative arrangement, material components, number | component 4
Roche, Collaboration and License (Immunotherapy) Agreement  
Performance Obligations  
Revenue, performance obligation, performance obligations, number 1
Roche, Collaboration and License (Immunotherapy) Agreement | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-07-01  
Performance Obligations  
Revenue, remaining performance obligation, expected timing of satisfaction, period 3 years 6 months
Clementia  
Performance Obligations  
Collaborative arrangement, material promises, number 4
Revenue, performance obligation, performance obligations, number 3
C Stone  
Performance Obligations  
Collaborative arrangement, material promises, number 6
Collaborative arrangement, material components, number | component 2
Revenue, performance obligation, performance obligations, number 3